1
|
Antoniuk O, Maranha A, Salvador JAR, Empadinhas N, Moreira VM. Bi- and tricyclic diterpenoids: landmarks from a decade (2013-2023) in search of leads against infectious diseases. Nat Prod Rep 2024; 41:1858-1894. [PMID: 39371026 DOI: 10.1039/d4np00021h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/08/2024]
Abstract
Covering: 2013 to 2023In an era where antimicrobial resistance severely threatens our ability to treat infections, the discovery of new drugs that belong to different chemical classes and/or bear original modes of action is urgently needed. In this case, diterpenoids comprise a productive field with a proven track record in providing new anti-infectives to tackle bacterial infections and malaria. This review highlights the potential of both naturally occurring and semi-synthetic bi- and tricyclic diterpenoids to become leads in search of new drugs to treat infections caused by bacteria, fungi, viruses and protozoan parasites. The literature from the last decade (2013-2023) is covered, focusing on naturally occurring and semi-synthetic bicyclic (labdanes and labdane-type) and tricyclic (all classes) diterpenoids, detailing their relevant biological activities in the context of infection, which are explained through structure-activity relationships.
Collapse
Affiliation(s)
- Olha Antoniuk
- Faculty of Pharmacy, University of Coimbra, Portugal.
- Centre for Neuroscience and Cell Biology, University of Coimbra, Portugal
- Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
| | - Ana Maranha
- Centre for Neuroscience and Cell Biology, University of Coimbra, Portugal
- Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
| | - Jorge A R Salvador
- Faculty of Pharmacy, University of Coimbra, Portugal.
- Centre for Neuroscience and Cell Biology, University of Coimbra, Portugal
- Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
| | - Nuno Empadinhas
- Centre for Neuroscience and Cell Biology, University of Coimbra, Portugal
- Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
| | - Vânia M Moreira
- Faculty of Pharmacy, University of Coimbra, Portugal.
- Centre for Neuroscience and Cell Biology, University of Coimbra, Portugal
- Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
- Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland
| |
Collapse
|
2
|
Saha P, Rahman FI, Hussain F, Rahman SMA, Rahman MM. Antimicrobial Diterpenes: Recent Development From Natural Sources. Front Pharmacol 2022; 12:820312. [PMID: 35295739 PMCID: PMC8918777 DOI: 10.3389/fphar.2021.820312] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 12/30/2021] [Indexed: 12/12/2022] Open
Abstract
Antimicrobial resistance has been posing an alarming threat to the treatment of infectious diseases over the years. Ineffectiveness of the currently available synthetic and semisynthetic antibiotics has led the researchers to discover new molecules with potent antimicrobial activities. To overcome the emerging antimicrobial resistance, new antimicrobial compounds from natural sources might be appropriate. Secondary metabolites from natural sources could be prospective candidates in the development of new antimicrobial agents with high efficacy and less side effects. Among the natural secondary metabolites, diterpenoids are of crucial importance because of their broad spectrum of antimicrobial activity, which has put it in the center of research interest in recent years. The present work is aimed at reviewing recent literature regarding different classes of natural diterpenes and diterpenoids with significant antibacterial, antifungal, antiviral, and antiprotozoal activities along with their reported structure-activity relationships. This review has been carried out with a focus on relevant literature published in the last 5 years following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 229 diterpenoids from various sources like plants, marine species, and fungi are summarized in this systematic review, including their chemical structures, classification, and significant antimicrobial activities together with their reported mechanism of action and structure-activity relationships. The outcomes herein would provide researchers with new insights to find new credible leads and to work on their synthetic and semisynthetic derivatives to develop new antimicrobial agents.
Collapse
Affiliation(s)
- Poushali Saha
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - Fahad Imtiaz Rahman
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - Fahad Hussain
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
| | - S. M. Abdur Rahman
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - M. Mukhlesur Rahman
- Medicines Research Group, School of Health, Sports and Bioscience, University of East London, London, United Kingdom
| |
Collapse
|
3
|
Holanda RJ, Deves C, Moreira-Dill LS, Guimarães CL, Marttinelli LKB, Fernandes CFC, Medeiros PSM, Pereira SS, Honda ER, Stábeli RG, Santos DS, Soares AM, Pereira da Silva LH. Plasmodium falciparum purine nucleoside phosphorylase as a model in the search for new inhibitors by high throughput screening. Int J Biol Macromol 2020; 165:1832-1841. [PMID: 33075341 DOI: 10.1016/j.ijbiomac.2020.10.062] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Revised: 09/28/2020] [Accepted: 10/09/2020] [Indexed: 10/23/2022]
Abstract
Studies have shown that inhibition of Plasmodium falciparum Purine Nucleoside Phosphorylase (PfPNP) blocks the purine salvage pathway in vitro and in vivo. In this study, PfPNP was evaluated as a model in the search for new inhibitors using surface plasmon resonance (SPR). Its expression, purification, oligomeric state, kinetic constants, calorimetric parameters and kinetic mechanisms were obtained. PfPNP was immobilized on a CM5 sensor chip and sensorgrams were produced through binding the enzyme to the substrate MESG and interactions between molecules contained in 10 fractions of natural extracts. The oligomeric state showed that recombinant PfPNP is a hexamer. The true steady-state kinetic parameters for the substrate inosine were: KM 17 μM, kcat 1.2 s-1, VMax 2.2 U/mg and kcat/KM 7 × 10-4; for MESG they were: KM 131 μM, kcat 2.4 s-1, VMax 4.4 U/mg and kcat/KM 1.8 × 10-4. The thermodynamic parameters for the substrate Phosphate were: ΔG - 5.8 cal mol-1, ΔH - 6.5 cal mol-1 and ΔS - 2.25 cal mol-1/degree. The ITC results demonstrated that the binding of phosphate to free PfPNP led to a significant change in heat and association constants and thermodynamic parameters. A sequential ordered mechanism was proposed as the kinetic mechanism. Three plant extracts contained molecules capable of interacting with PfPNP, showing different levels of affinity. The identification of plant extract fractions containing molecules that interact with recombinant PfPNP using SRP validates this target as a model in the search for new inhibitors. In this study, we showed for the first time the true steady-state kinetic parameters for reactions catalyzed by PfPNP and a model using PfPNP as a target for High-throughput Screening for new inhibitors through SPR. This knowledge will allow for the development of more efficient research methods in the search for new drugs against malaria.
Collapse
Affiliation(s)
- Rudson J Holanda
- Universidade Federal do Amazonas, UFAM, campus Humaitá, Amazonas, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil.
| | - Candida Deves
- Centro de Pesquisa em Biologia Molecular e Funcional, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Leandro S Moreira-Dill
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Cesar L Guimarães
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Leonardo K B Marttinelli
- Centro de Pesquisa em Biologia Molecular e Funcional, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Carla F C Fernandes
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Laboratório de Engenharia de Anticorpos, Fiocruz Rondônia, Porto Velho, Rondônia, Brazil; Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Ceará, Fortaleza, Ceará, Brazil
| | - Patrícia S M Medeiros
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Soraya S Pereira
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Laboratório de Engenharia de Anticorpos, Fiocruz Rondônia, Porto Velho, Rondônia, Brazil
| | - Eduardo R Honda
- Instituto de Pesquisa em Patologias Tropicais de Rondônia, IPEPATRO e Laboratório Central, LACEN, Porto Velho, Rondônia, Brazil
| | - Rodrigo G Stábeli
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Fundação Oswaldo Cruz, FIOCRUZ, Plataforma Bi-institucional de Medicina Translacional, Ribeirão Preto, São Paulo, Brazil
| | - Diógenes S Santos
- Centro de Pesquisa em Biologia Molecular e Funcional, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil; Centro Universitário São Lucas, UniSL, Porto Velho, Rondônia, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Brazil.
| | - Luiz H Pereira da Silva
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| |
Collapse
|
4
|
Mahadeo K, Grondin I, Herbette G, Palama TL, Bouchemal N, Soulange J, Laulloo SJ, Sadeyen J, Humeau L, Frederich M, Gauvin-Bialecki A, Kodja H. A 1H NMR-based metabolomic approach to study the production of antimalarial compounds from Psiadia arguta leaves (pers.) voigt. PHYTOCHEMISTRY 2020; 176:112401. [PMID: 32464510 DOI: 10.1016/j.phytochem.2020.112401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Revised: 05/11/2020] [Accepted: 05/11/2020] [Indexed: 06/11/2023]
Abstract
Psiadia arguta (Asteraceae) is endemic to the island of Mauritius in the Indian Ocean. The species is traditionally used to treat various ailments, such as its use as an expectorant or for the treatment of bronchitis and asthma. Preliminary biological screenings have displayed the antimalarial (Plasmodium falciparum) and anticancer (HeLa human cell line) potential of P. arguta leaves. The phytochemical investigation of this plant has led to the isolation and characterization of sixteen compounds including five antiplasmodial molecules. The accumulation of the antiplasmodial compounds during the growth of the plant was studied by a 1H NMR-based metabolomic approach. In order to identify factors influencing the production of bioactive compounds, young plants of P. arguta were multiplied using in vitro culture techniques, and micro-propagated plants at different stages of development were acclimatized and followed for the experiments. The multivariate data analysis showed an accumulation of four bioactive compounds in the leaves of P. arguta when these plants were challenged with a biotic stress: labdan-13(E)-en-8α-ol-15-yl acetate, labdan-8α-ol-15-yl acetate, labdan-13(E)-ene-8α-ol-15-diol, and (8R,13S)-labdan-8,15-diol.
Collapse
Affiliation(s)
- Keshika Mahadeo
- Laboratoire de Chimie des Substances Naturelles et des Sciences des Aliments, Faculté des Sciences et Technologies, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744, St Denis Cedex 9, La Réunion, France; UMR Qualisud, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744, St Denis Cedex 9, La Réunion, France
| | - Isabelle Grondin
- Laboratoire de Chimie des Substances Naturelles et des Sciences des Aliments, Faculté des Sciences et Technologies, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744, St Denis Cedex 9, La Réunion, France
| | - Gaëtan Herbette
- Aix-Marseille Univ, CNRS, Centrale Marseille, FSCM, Spectropole, Campus de St Jérôme-Service 511, 13397, Marseille, France
| | - Tony L Palama
- Université Sorbonne Paris Nord, Laboratoire de Chimie, Structures, Propriétés de Biomatériaux et d'Agents Thérapeutiques, CSPBAT, CNRS, UMR 7244, F, 93430, Villetaneuse, France
| | - Nadia Bouchemal
- Université Sorbonne Paris Nord, Laboratoire de Chimie, Structures, Propriétés de Biomatériaux et d'Agents Thérapeutiques, CSPBAT, CNRS, UMR 7244, F, 93430, Villetaneuse, France
| | - Joyce Soulange
- Department of Agriculture and Food Science, Faculty of Agriculture, The University of Mauritius, Mauritius
| | | | - Joelle Sadeyen
- UMR Peuplement Végétaux et Bio-agresseurs en Milieu Tropical, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744 St Denis Cedex 9, La Réunion, France
| | - Laurence Humeau
- UMR Peuplement Végétaux et Bio-agresseurs en Milieu Tropical, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744 St Denis Cedex 9, La Réunion, France
| | - Michel Frederich
- Université de Liège, Département de Pharmacie, Centre Interfacultaire de Recherche sur le Médicament (CIRM), Laboratoire de Pharmacognosie, Campus du Sart-Tilman, Quartier Hôpital, Avenue Hippocrate, 15 B36 4000 Liège, Belgium
| | - Anne Gauvin-Bialecki
- Laboratoire de Chimie des Substances Naturelles et des Sciences des Aliments, Faculté des Sciences et Technologies, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744, St Denis Cedex 9, La Réunion, France
| | - Hippolyte Kodja
- UMR Qualisud, Université de La Réunion, 15 Avenue René Cassin, CS 92 003, 97 744, St Denis Cedex 9, La Réunion, France.
| |
Collapse
|